by
Amanda Doreson, Project Manager | November 08, 2006
Radiosurgery with the CyberKnife System has proven to be quite successful in treating our lung cancer patients, said John J. Kresl MD, PhD of Arizona Oncology Services at St. Joseph's Hospital and Barrow Neurological Institute. Because these new tools from Accuray are non-invasive, we believe they will enhance our ability to treat lung tumors, including those in patients who may not be able to withstand the complications that could result from the implantation of fiducials.
A study in the most recent issue of the New England Journal of Medicine showed that regular screenings detected lung cancer in its earliest stages, and was curable when treatment quickly followed, said Eric P. Lindquist, senior vice president and chief marketing officer. We believe the Accuray CyberKnife System offers these stage I lung cancer patients an ideal alternative. With over 1000 lung tumor patients treated on the CyberKnife System to date, we believe that radiosurgery will continue to be a viable treatment option for lung cancer patients.

Ad Statistics
Times Displayed: 20570
Times Visited: 396 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
For more information, please visit www.accuray.com.
Back to HCB News